Publications by authors named "Terence D Rhodes"

Article Synopsis
  • Cytokine storms caused by COVID-19 can lead to severe health issues, particularly in cancer patients undergoing immunotherapy due to heightened immune responses.
  • A study involving over 12,000 cancer patients aimed to explore how baseline immunosuppression and immunotherapy affect the severity of COVID-19 and the likelihood of cytokine storms.
  • Results indicated no significant differences in COVID-19 severity or cytokine storm occurrence among patients receiving immunotherapy compared to those not receiving any cancer treatment prior to their COVID-19 diagnosis.
View Article and Find Full Text PDF
Article Synopsis
  • The COVID-19 pandemic has affected cancer patients differently across various regions in the U.S., showing that these patients are at a higher risk for severe COVID-19 complications.
  • This study tracked and analyzed COVID-19 outcomes among cancer patients diagnosed between March and November 2020 across different U.S. census divisions, focusing on factors that may influence their health outcomes.
  • Results indicated significant variability in 30-day mortality rates among cancer patients in different centers, ranging from 5.2% to 26.6%, suggesting that geographic location and healthcare center characteristics play a crucial role in these outcomes.
View Article and Find Full Text PDF

Human immunodeficiency virus type 1 (HIV-1) recombination occurs during reverse transcription when parts of the two co-packaged RNAs are used as templates for DNA synthesis. It was previously hypothesized that HIV-1 Gag polyproteins preferentially encapsidate the RNA from which they were translated (cis-packaging hypothesis). This hypothesis implies that mutants encoding Gag that cannot efficiently package viral RNA are selected against at two levels: these mutants do not generate infectious virus, and these mutants are not efficiently rescued by the wild-type virus because the mutant RNAs are packaged at much lower levels than are those of the wild-type genome.

View Article and Find Full Text PDF

Human immunodeficiency virus type 1 (HIV-1) exhibits a high level of genetic variation generated by frequent mutation and genetic recombination during reverse transcription. We have measured HIV-1 recombination rates in T cells in one round of virus replication. It was recently proposed that HIV-1 recombines far more frequently in macrophages than in T cells.

View Article and Find Full Text PDF

Genetic recombination increases diversity in HIV-1 populations, thereby allowing variants to escape from host immunity or antiviral therapies. In addition to the currently described nine subtypes of HIV-1, many of the circulating strains are intersubtype recombinants. In this study, we determined the recombination rate between two HIV-1 subtype C viruses and between a subtype B virus and a subtype C virus during a single round of virus replication.

View Article and Find Full Text PDF

Recombination is a major mechanism that generates variation in populations of human immunodeficiency virus type 1 (HIV-1). Mutations that confer replication advantages, such as drug resistance, often cluster within regions of the HIV-1 genome. To explore how efficiently HIV-1 can assort markers separated by short distances, we developed a flow cytometry-based system to study recombination.

View Article and Find Full Text PDF

We have identified a region near the C terminus of capsid (CA) of murine leukemia virus (MLV) that contains many charged residues. This motif is conserved in various lengths in most MLV-like viruses. One exception is that spleen necrosis virus (SNV) does not contain a well-defined domain of charged residues.

View Article and Find Full Text PDF